CD4 and neoplasm: To address these possibilities in the BLM treatment, we have first assessed if BLM injection did significantly modify the number of B cells, CD4+ T cells, CD8+ T cells, NK cells, dendritic cells, monocytes/macrophages or MDSC in spleen of tumor- bearing mice (Figure 3a).